SGMT
Sagimet Biosciences Inc.
+0.50 (+4.78%)10.96USD358K成交股數–市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | 2.0M | 2.0M | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 11.5M | 7.0M | 9.7M | 7.2M | 15.3M | 14.2M | 12.7M | 6.3M | 5.3M | 5.0M | – | 4.7M |
| 銷售管理費用 | 4.3M | 4.7M | 4.6M | 4.7M | 4.5M | 4.0M | 4.2M | 4.3M | 3.5M | 4.5M | – | 2.4M |
| 營業利益 | −15.8M-20% | −11.7M-36% | −14.3M-15% | −11.9M+13% | −19.9M+127% | −18.2M+144% | −16.9M | −10.6M+50% | −8.8M | −7.5M | – | −7.1M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | -372.6% | – | – |
| 稅後淨利 | −14.0M-23% | −10.7M-34% | −12.9M-12% | −10.4M+28% | −18.2M+174% | −16.2M+155% | −14.6M | −8.1M+20% | −6.6M | −6.4M | – | −6.8M |
| 淨利率 | – | – | – | – | – | – | – | – | – | -317.7% | – | – |
| 稀釋 EPS | -0.26-54% | -0.33-37% | -0.40-11% | -0.32+28% | -0.56+143% | -0.52+49% | -0.45 | -0.25-99% | -0.23 | -0.35 | – | -35.80 |
| 稀釋股數 | 53.1M | 32.6M | 32.5M | 32.2M | 32.2M | 31.4M | 32.1M | 31.9M | 29.0M | 18.2M | – | 190K |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 166M | 36.6M | 32.5M | 42.3M | 64.7M | 75.8M | 77.0M | 96.0M | 177M | 102M | – | 18.5M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 263M | 108M | 128M | 137M | 146M | 160M | 175M | 189M | 195M | 103M | – | 21.5M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 7.3M | – | – | – | 7.2M | 4.5M | 4.1M | 5.7M | 4.5M | 5.1M | – | 5.3M |
| 股東權益 | 256M | 102M | 119M | 130M | 139M | 156M | 171M | 183M | 190M | 97.9M | – | −198M |
| 負債比 | 2.8% | – | – | – | 4.9% | 2.8% | 2.3% | 3.0% | 2.3% | 4.9% | – | 24.6% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −8.6M | – | – | −14.5M+134% | – | – | – | −6.2M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2023 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2023 年度 · 2.0M
| Single Reportable | 2.0M | 100.0% | – |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −51.0M | –% | -1.58 | – |
| FY2024 | – | – | −45.6M | –% | -1.45 | – |
| FY2023 | 2.0M | – | −27.9M | -1,393.8% | -2.66 | – |
| FY2022 | – | – | −30.5M | –% | -165.20 | – |